HOME › DRUGS › MIRVETUXIMAB SORAVTANSINE
ACTIVE SUBSTANCE / INN

MIRVETUXIMAB SORAVTANSINE

Brand name(s): Elahere
EMA LISTED
AUTHORISED
Ovarian Neoplasms;Fallopian Tube Neoplasms;Peritoneal Neopla…
ACTIVE SUBSTANCE
Mirvetuximab Soravtansine
REGULATORS
EMA
SPONSORS / MAH
AbbVie Deutschland GmbH & Co. KG
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
ElahereAbbVie Deutschland GmbH & Co. KGAuthorised14/11/2024Ovarian Neoplasms;Fallopian Tube Neoplasms;Peritoneal Neoplasms

FULL INTELLIGENCE ON MIRVETUXIMAB SORAVTANSINE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →